Home / Market News / $RLMD

$RLMD news and market catalysts

The 1 most recent market catalysts affecting $RLMD, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

1 catalysts 0 high impact 1 bullish 0 bearish Pharmaceuticals
Sep 11, 2026 Corporate Catalyst Bullish Impact 65
Relmada Therapeutics shares are trading higher after Form 4 filings showed its executives bought company stock.
The Form 4 filings indicating executive stock purchases are a strong positive signal for Relmada Therapeutics. Insider buying suggests that those with the most intimate knowledge o…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.